Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 7Gastrointestinal 4Thoracic 3Genitourinary 3Tumor-Agnostic 1Sarcoma 1Head & Neck 1Endocrine 1

Conditions

Urinary Bladder Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pafolacianine × Genitourinary × Clear all
NCT06434909 2026-06-01

CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer

Indiana University

Phase 2 Completed
9 enrolled
Genitourinary

Prostatic Neoplasms

NCT02852252 2021-06-18

Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry

University of Pennsylvania

Completed
291 enrolled
GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Stomach Neoplasms

NCT02645409 2020-02-25

Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma

Indiana University

Phase NA Completed
14 enrolled 6 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡